621
Participants
Start Date
September 30, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
NER1006
The subject will self-administer the first dose of the assigned investigational product in the evening prior to the scheduled colonoscopy and take mandatory additional clear fluid. Subject will take the second dose together with mandatory additional clear fluids on the morning of the colonoscopy.
Trisulfate solution
The subject will self-administer the first dose of the assigned investigational product in the evening prior to the scheduled colonoscopy and take mandatory additional clear fluid. Subject will take the second dose together with mandatory additional clear fluids on the morning of the colonoscopy.
Long Island Gastrointestinal Research Group, LLP, Great Neck
MGG Group Co., Inc., Chevy Chase Clinical, Chevy Chase
Investigative Clinical Research, Annapolis
Trial Management Associates, LLC, Wilmington
Peters Medical Research, High Point
Wake Research Associates, LLC, Raleigh
Cumberland Research Associates, LLC, Fayetteville
Investigative Clinical Research, LLC, Mentor
Consultants for Clinical Research, Cincinnati
Clinical Research Institute of Michigan, LLC, Chesterfield
Advanced Research Institute, Ogden
Anaheim Clinical Trials, Anaheim
Lead Sponsor
Norgine
INDUSTRY